Design and Synthesis of O ‐Dialkylaminoalkyl Substituted Urolithin Derivatives: DNA Topoisomerase IIα Inhibition With Promising Antiproliferative Activity
Archiv der Pharmazie · 2025
DOI: 10.1002/ardp.70009 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archiv der Pharmazie, 2025. Verfasst von Xintong Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine, Department of Natural Products Chemistry,…. Hauptthemen laut MEDLINE: Topoisomerase II Inhibitors, DNA Topoisomerases, Type II, Antineoplastic Agents, Drug Design. Die Arbeit nennt 51 Literaturangaben. Gefördert von: This study was financially supported by the Program for Changjiang Scholars and Innovative Research Team in University (IRT_17R68), Germplasm innovation and ef….
Abstract (Originalsprache)
Based on the pharmacophore structural characteristics of topoisomerase II (TopoII) inhibitors: (i) planar polyaromatic skeleton; (ii) the cation core; (iii) a groove‐binding side chain moiety, 16 urolithin derivatives with O ‐dialkylaminoalkyl substitutions were designed and synthesized. Most of the synthesized compounds showed improved TopoIIα inhibitory and antiproliferative activities. 20 with the best TopoIIα inhibitory activity also exhibited excellent antiproliferative activity with IC 50 values of 0.91 ± 0.01, 1.93 ± 0.04, and 2.84 ± 0.34 μM against the MDA‐MB‐231, HeLa, and A549 cell lines, being about 12.55, 3.95, and 2.17 times more active than VP‐16 (IC 50 11.42 ± 0.82, 7.63 ± 0.46, and 6.15 ± 0.43 μM, respectively). Meanwhile, 20 exhibited weak toxicity to normal cells. In addition, 20 exerted anti‐migration and anti‐invasion activity against MDA‐MB‐231 cells. Our results supported that 20 might act as TopoIIα inhibitor with the potential to become a new type of antitumor drug lead.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine, Department of Natural Products Chemistry, School of Pharmaceutical Sciences, Shandong University, Jinan, China.
ORCID-Profile: Chunhua Lu
Förderung
- This study was financially supported by the Program for Changjiang Scholars and Innovative Research Team in University (IRT_17R68), Germplasm innovation and ef…
Zitieren
APA
Li, X., Zhang, X., Yin, C., Lu, C., & Shen, Y. (2025). Design and Synthesis of O ‐Dialkylaminoalkyl Substituted Urolithin Derivatives: DNA Topoisomerase IIα Inhibition With Promising Antiproliferative Activity. Archiv der Pharmazie. https://doi.org/10.1002/ardp.70009
Vancouver
Li X, Zhang X, Yin C, Lu C, Shen Y. Design and Synthesis of O ‐Dialkylaminoalkyl Substituted Urolithin Derivatives: DNA Topoisomerase IIα Inhibition With Promising Antiproliferative Activity. Archiv der Pharmazie. 2025. doi:10.1002/ardp.70009
BibTeX
@article{Li2025,
author = {Li, Xintong and Zhang, Xiaochun and Yin, Chan and Lu, Chunhua and Shen, Yuemao},
title = {Design and Synthesis of O ‐Dialkylaminoalkyl Substituted Urolithin Derivatives: DNA Topoisomerase IIα Inhibition With Promising Antiproliferative Activity},
journal = {Archiv der Pharmazie},
year = {2025},
doi = {10.1002/ardp.70009}
}
EUVIMED